Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis (Q38881790)

7 September 2017

1 reference

title

Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis (English)

1 reference

7 September 2017

0 references

1 reference

Hanna A Jensen

1 reference

7 September 2017

Jawahar L Mehta

series ordinal

1 reference

7 September 2017

publication date

30 June 2016

1 reference

Expert Review of Cardiovascular Therapy

7 September 2017

published in

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

1021-1033

1 reference

Vascular endothelium - Gatekeeper of vessel health.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

The endothelium: influencing vascular smooth muscle in many ways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Oxidized LDL, LOX-1 and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial dysfunction: a comprehensive appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Laminar shear stress regulates mitochondrial dynamics, bioenergetics responses and PRX3 activation in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Oxidative stress and early atherosclerosis: novel antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Comprehensive assessment of vascular health in patients; towards endothelium-guided therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

The assessment of endothelial function: from research into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

ADMA: an emerging cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Oxidized LDL and NO synthesis--Biomarkers of endothelial dysfunction and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial dysfunction: causes and consequences in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial and antithrombotic actions of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Statin effects beyond lipid lowering--are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Inhibition of LOX-1 by statins may relate to upregulation of eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial dysfunction and vascular disease - a 30th anniversary update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial dysfunction: a strategic target in the treatment of hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Interrelationship of Free Oxygen Radicals and Endothelial Dysfunction--Modulation by Statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Oxidative stress and smoking-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Analysis of antihypertensive effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Regulation of atherosclerotic plaque inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Anti-inflammatory therapies for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Inflammation and immune system contribution to the etiology of atherosclerosis: mechanisms and methods of assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and cardiac fibroblast growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

LOX-1: A New Target for Therapy for Cardiovascular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Interferon-γ: Promising therapeutic target in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Strategies in the design of nanoparticles for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Vascular injury and repair: a potential target for cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

CD40 and autoimmunity: the dark side of a great activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Costimulation blockade in the treatment of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial dysfunction in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Identifying functional microRNAs in macrophages with polarized phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Flow-Dependent Epigenetic DNA Methylation in Endothelial Gene Expression and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Vaccination strategies in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

miRNA expression in the failing human heart: functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Effects of shear stress on endothelial cells: go with the flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial progenitor cell therapy in atherosclerosis: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Stem cell-based therapies for atherosclerosis: perspectives and ongoing controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Differentiation of multipotent vascular stem cells contributes to vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial and smooth muscle cell transformation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Inflammatory stress exacerbates the progression of cardiac fibrosis in high-fat-fed apolipoprotein E knockout mice via endothelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Endothelial-to-mesenchymal transition drives atherosclerosis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

Virtual Histology Evaluation of Atherosclerosis Regression During Atorvastatin and Ezetimibe Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2016.1207527

10.1080/14779072.2016.1207527

21 January 2018

Identifiers

DOI

1 reference

release_2fs6chiyxvedxlynqix7gub5qq

7 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2fs6chiyxvedxlynqix7gub5qq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference